BPI Boston Continuous bioprocessing next logical step after single-use adoption, Pall 06-Oct-2016 By Dan Stanton The strong adoption of single-use technology is enabling industry to transition towards continuous bioprocessing systems, says Pall Corporation.
BPI Europe 2016 Pall: Bioprocessing's future is made of virtual reality 27-Apr-2016 By Dan Stanton Pall Corporation has embraced a virtual reality platform to showcase some of its bioprocessing systems at industry shows.
Dispatches from BPI Europe 2016 Looking to make third wave biosimilars? MOA crucial for cell line development, Formycon 15-Apr-2016 By Dan Stanton Fully understanding a molecule’s mode-of-action (MOA) will be essential as industry begins developing the third generation of biosimilar products, according to Formycon.
Dispatches from BPI Europe 2016 Steel crazy after all these years? Bioprocess industry talks facility of future 13-Apr-2016 By Dan Stanton Stainless steel systems have become the niche single-use was five years ago, but could a shift to continuous manufacturing drive its return?
Dispatches from BPI Europe 2016 GE Healthcare: Expanded Austrian plant incorporating ex-Thermo media business 12-Apr-2016 By Dan Stanton GE Healthcare has expanded a facility in Austria to house the European wing of the Hyclone cell culture business it acquired from Thermo Fisher.
Dispatches from BPI Europe 2016 Roche: Bispecific and complex mAbs driving process development 12-Apr-2016 By Dan Stanton The increasing complexity of biopharmaceuticals is driving process development innovation according to Swiss drug firm Roche.